Download (635 KB)
The University of Texas MD Anderson Cancer Center
Cutaneous melanoma, BCL2, targeted therapy, apoptosis regulation, cell growth
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.
ITERT Undergraduate Summer Research Training Program
Dantas, Felipe; de Groot, Evelyn; Ruiz Elizondo, Cesar Augusto; Guerrieri, Renato; Davies, Michael A. MD, PhD; and Gopal, Vashisht YN, "BCLXL and BCLXS as Resistance Markers for BCL2 Inhibitors in Melanoma" (2021). Summer Experience 2021. 243.